hyphens pharma

BOARDS of directors play a key role in ensuring transparency, accountability, performance orientation, good processes and practices in companies.

SINGAPORE’S leading specialty pharmaceutical and consumer healthcare group, Hyphens Pharma International, is expanding its South-east Asia footprint beyond the five countries that it is already in, sa...

CATALIST-LISTED Hyphens Pharma International on Friday (May 27) said property and retail company Metro Holdings has agreed to invest S$6 million for a 10 per cent stake in the former’s digital healtht...

CGS-CIMB on Friday (Jan 7) initiated coverage on Hyphens Pharma with an "add" call and target price of S$0.36. The research team believes the pharmaceutical and consumer healthcare company's share pri...

CATALIST-LISTED Hyphens Pharma has inked an exclusive licensing deal to commercialise an antibody biosimilar drug in Singapore, Malaysia, and the Philippines, in order to expand their dermatology prod...

CATALIST-LISTED Hyphens Pharma will acquire Novem Healthcare, Novem Pharma and Novem Sciences (Novem companies) for S$16.3 million to augment its current healthcare products and services.

KGI Securities has upgraded its call on Catalist-listed Hyphens Pharma from "neutral" to "outperform" with a higher target price of S$0.43 compared to S$0.36 previously, upon rolling forward estimates...

HYPHENS Pharma International is planning to cement its regional presence by appointing dermo-cosmetic products and medical devices distributor and promoter JSPharma as an exclusive distributor of its ...

HYPHENS Pharma International's net profit shrank by 53 per cent to S$847,000 for the third quarter, from S$1.8 million a year ago.